Select Medical Holdings Co. (NYSE:SEM) Director Parvinderjit S. Khanuja Purchases 21,000 Shares

Select Medical Holdings Co. (NYSE:SEM) Director Parvinderjit S. Khanuja acquired 21,000 shares of the firm’s stock in a transaction dated Monday, May 5th. The stock was bought at an average price of $15.02 per share, with a total value of $315,420.00. Following the purchase, the director now directly owns 65,089 shares in the company, valued at approximately $977,636.78. This trade represents a 47.63 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Select Medical Price Performance

Shares of NYSE:SEM opened at $14.43 on Wednesday. Select Medical Holdings Co. has a 12 month low of $14.03 and a 12 month high of $40.98. The firm has a market capitalization of $1.86 billion, a P/E ratio of 8.75, a P/E/G ratio of 0.64 and a beta of 1.40. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company’s fifty day moving average price is $16.76 and its 200 day moving average price is $21.47.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.01). The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The firm’s revenue for the quarter was down 24.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.75 EPS. As a group, sell-side analysts predict that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical announced that its Board of Directors has authorized a share buyback program on Thursday, May 1st that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the health services provider to reacquire up to 42.6% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

Select Medical Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be given a dividend of $0.0625 per share. The ex-dividend date is Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.73%. Select Medical’s dividend payout ratio (DPR) is presently 18.66%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of Select Medical by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider’s stock worth $239,640,000 after buying an additional 131,228 shares during the period. Dimensional Fund Advisors LP lifted its position in Select Medical by 1.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider’s stock worth $83,533,000 after acquiring an additional 62,585 shares during the period. Invesco Ltd. grew its stake in shares of Select Medical by 48.6% in the 4th quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider’s stock valued at $49,838,000 after purchasing an additional 864,852 shares during the last quarter. Principal Financial Group Inc. raised its stake in shares of Select Medical by 3.1% during the first quarter. Principal Financial Group Inc. now owns 2,476,816 shares of the health services provider’s stock worth $41,363,000 after purchasing an additional 73,308 shares during the last quarter. Finally, Hood River Capital Management LLC lifted its holdings in shares of Select Medical by 404.8% during the fourth quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider’s stock worth $33,096,000 after purchasing an additional 1,407,902 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research note on Monday, February 24th. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Royal Bank of Canada cut their price target on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday, February 24th. Finally, Mizuho assumed coverage on Select Medical in a research report on Wednesday, April 16th. They set an “outperform” rating and a $25.00 price objective for the company. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Select Medical presently has a consensus rating of “Moderate Buy” and a consensus price target of $26.80.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.